SCHEMBL7659554

SCHEMBL7659554

CC(=O)On1ncc2cc3[nH]c(=O)c(-c4cn(Cc5cccc(CN)c5)c5ccccc45)nc3cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
KDR P35968 2/20 0.36
PDE4A P27815 5/20 0.35
PDE4B Q07343 5/20 0.35
PDE4C Q08493 5/20 0.35
PDE4D Q08499 5/20 0.35
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
SIRT2 Q8IXJ6 1/20 0.34
F2RL3 Q96RI0 1/20 0.34
TP53 P04637 2/20 0.34
USP2 O75604 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CASP1 P29466 2/20 0.34
CASP7 P55210 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7662876 0.95 CA12 (0.37) CA12CA1CA2CA9KDR
SCHEMBL7665490 0.90 ACKR3 (0.33) CA12CA1CA2CA9KDR
SCHEMBL7663434 0.89 TP53 (0.38) TP53USP2POLBMAPT
SCHEMBL7657220 0.86 CAMK2D (0.42) KDR
SCHEMBL7662310 0.85 IDO1 (0.36) CA12CA1CA2CA9KDR
Acetic Acid SCHEMBL7657913 0.85 PDE4A (0.42) CA12CA1CA2CA9KDR
SCHEMBL7658124 0.84 CA12 (0.38) CA12CA1CA2CA9KDR
Acetic Acid SCHEMBL7659539 0.82 MKNK1 (0.41) CA12CA1CA2CA9KDR
Acetic Acid SCHEMBL7658112 0.82 PDE4A (0.41) CA12CA1CA2CA9KDR
Acetic Acid SCHEMBL7807324 0.82 IDO1 (0.43) CA12CA1CA2CA9KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458792-B1 MEDICAMENT FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL, BRONCHOPULMONARY, CARDIOVASCULAR, ONCOLOGICAL OR CNS-DEGENERATIVE DISORDERS. ASTRAZENECA AB (SE) 2002-10-01 US disclosed